Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19-Reference-Cited by-同舟云学术

Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19

Published:2021-08-08 Issue:9 Volume:99 Page:917-921
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Abers Michael S¹^ORCID,Rosen Lindsey B¹,Delmonte Ottavia M¹,Shaw Elana¹,Bastard Paul²³^ORCID,Imberti Luisa⁴,Quaresima Virginia⁴,Biondi Andrea⁵,Bonfanti Paolo⁶,Castagnoli Riccardo¹⁷^ORCID,Casanova Jean‐Laurent²³⁸⁹,Su Helen C¹,Notarangelo Luigi D¹,Holland Steven M¹,Lionakis Michail S¹^ORCID

Affiliation:

1. Laboratory of Clinical Immunology & Microbiology National Institute of Allergy & Infectious Diseases National Institutes of Health Bethesda MD USA

2. Laboratory of Human Genetics of Infectious Diseases Necker Branch INSERM U1163 Necker Hospital for Sick Children Paris France

3. Imagine Institute University of Paris Paris France

4. CREA Laboratory Diagnostic Department ASST Spedali Civili di Brescia Brescia Italy

5. Pediatric Department and Centro Ricerca M. Tettamanti Fondazione MBBM‐Ospedale San Gerardo University of Milano‐Bicocca Monza Italy

6. Department of Infectious Diseases San Gerardo Hospital University of Milano‐Bicocca Monza Italy

7. Department of Pediatrics Fondazione IRCCS Policlinico San Matteo University of Pavia Pavia Italy

8. St. Giles Laboratory of Human Genetics of Infectious Diseases Rockefeller Branch The Rockefeller University New York NY USA

9. Howard Hughes Medical Institute New York NY USA

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Fondation pour la Recherche Médicale

Agence Nationale de la Recherche

National Human Genome Research Institute

National Institutes of Health

National Center for Advancing Translational Sciences

Regione Lombardia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12495

Reference13 articles.

1. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

2. Longitudinal single‐cell epitope and RNA‐seq reveals the immunological impact of type 1 interferon autoantibodies in critical COVID‐19;Wijst MVS;Sci Transl Med,2021

3. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

4. Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2

5. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children;Clinical and Experimental Immunology;2024-07-19

2. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies;Journal of Experimental Medicine;2024-07-17

3. Harnessing the power of IFN for therapeutic approaches to COVID-19;Journal of Virology;2024-05-14

4. In search of a function for human type III interferons: insights from inherited and acquired deficits;Current Opinion in Immunology;2024-04

5. The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication;2024-03-27